In the BioHarmony Drug Report Database

"Preview" Icon

Pyrimethamine

Daraprim (pyrimethamine) is a small molecule pharmaceutical. Pyrimethamine was first approved as Daraprim on 1982-01-01. It is used to treat aids-related opportunistic infections, falciparum malaria, malaria, and toxoplasmosis in the USA. It is known to target multidrug and toxin extrusion protein 2, multidrug and toxin extrusion protein 1, Pteridine reductase, and beta-hexosaminidase subunit beta.

 

Trade Name

 

Daraprim
 

Common Name

 

pyrimethamine
 

ChEMBL ID

 

CHEMBL36
 

Indication

 

aids-related opportunistic infections, falciparum malaria, malaria, toxoplasmosis
 

Drug Class

 

Image (chem structure or protein)

Pyrimethamine structure rendering